China vs Tajikistan: Previously treated cases tested for RR-/MDR-TB
China
92.0%
in 2024
Tajikistan
91.0%
in 2024
China rank
79th
Tajikistan rank
82nd
Previously treated cases tested for RR-/MDR-TB over time
- China
- Tajikistan
How they compare
China currently reports 92.0% against 91.0% in Tajikistan, a difference of 1.0%.
The two have swapped places 3 times across 13 shared years of data; in 2012 it was Tajikistan ahead.
China ranks 79th and Tajikistan ranks 82nd of 180 countries.
Tajikistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | China | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 62.0% | 73.4% | 11.4% | Tajikistan |
| 2020s | 92.2% | 96.0% | 3.8% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, China or Tajikistan?
- China, at 92.0% against 91.0% in Tajikistan as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between China and Tajikistan?
- 1.0%, with China ahead.
- How many years of comparable data are there for China and Tajikistan?
- 13 years are reported by both, from 2012 to 2024.
- How do China and Tajikistan rank globally for previously treated cases tested for rr-/mdr-tb?
- China ranks 79th and Tajikistan ranks 82nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.